Emerging Immunotherapy Approaches for Treating Prostate Cancer

被引:10
|
作者
Meng, Lingbin [1 ]
Yang, Yuanquan [1 ]
Mortazavi, Amir [1 ]
Zhang, Jingsong [2 ]
机构
[1] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, 12902 USF Magnolia Dr, Tampa, FL 33612 USA
关键词
immunotherapy; prostate cancer; immune checkpoint inhibitors; bispecific antibodies; CAR T cells; vaccines; cytokines; immunotherapeutic combinations; CAR-T-CELLS; IMMUNE-CHECKPOINT; DOUBLE-BLIND; PHASE-III; PLUS DOCETAXEL; CLINICAL-TRIAL; SIPULEUCEL-T; TUMOR MICROENVIRONMENT; DNA VACCINE; ANTIGEN;
D O I
10.3390/ijms241814347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunotherapy has emerged as an important approach for cancer treatment, but its clinical efficacy has been limited in prostate cancer compared to other malignancies. This review summarizes key immunotherapy strategies under evaluation for prostate cancer, including immune checkpoint inhibitors, bispecific T cell-engaging antibodies, chimeric antigen receptor (CAR) T cells, therapeutic vaccines, and cytokines. For each modality, the rationale stemming from preclinical studies is discussed along with outcomes from completed clinical trials and strategies to improve clinical efficacy that are being tested in ongoing clinical trials. Imperative endeavors include biomarker discovery for patient selection, deciphering resistance mechanisms, refining cellular therapies such as CAR T cells, and early-stage intervention were reviewed. These ongoing efforts instill optimism that immunotherapy may eventually deliver significant clinical benefits and expand treatment options for patients with advanced prostate cancer.
引用
收藏
页数:26
相关论文
共 50 条
  • [11] Current approaches to treating hormone refractory prostate cancer
    Karyakin, O. B.
    ONKOUROLOGIYA, 2011, 7 (01): : 101 - 106
  • [12] Emerging minimally invasive techniques for treating localized prostate cancer
    Ahmed, S
    Lindsey, B
    Davies, J
    BJU INTERNATIONAL, 2005, 96 (09) : 1230 - 1234
  • [13] New Insights and Emerging Therapeutic Approaches in Prostate Cancer
    Licitra, Fabrizio
    Giovannelli, Pia
    Di Donato, Marzia
    Monaco, Alessandra
    Galasso, Giovanni
    Migliaccio, Antimo
    Castoria, Gabriella
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [14] Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options
    Chakravarty, Dimple
    Huang, Li
    Kahn, Matthew
    Tewari, Ashutosh K.
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (04) : 487 - 510
  • [15] Immunotherapy in prostate cancer: Emerging strategies against a formidable foe
    Bilusic, Marijo
    Heery, Christopher
    Madan, Ravi A.
    VACCINE, 2011, 29 (38) : 6485 - 6497
  • [16] Immunotherapy: an emerging strategies against prostate castration resistant cancer
    Mansi, Laura
    Thiery-Vuillemin, Antoine
    Kalbacher, Elsa
    Thierry Nguyen
    Maurina, Tristan
    Nallet, Jeremie
    Kim, Stefano
    Borg, Christophe
    Kleinclauss, Francois
    Pivot, Xavier
    Adotevi, Olivier
    BULLETIN DU CANCER, 2012, 99 : S57 - S65
  • [17] New approaches and prospects of immunotherapy and gene therapy for prostate cancer
    Bibi, Roshni
    Sarkar, Koustav
    JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2024, 8 (02) : 119 - 161
  • [18] Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology
    Yu, Zongchao
    Mo, Zhongcheng
    Qiu, Yuan
    Lu, Hengzhe
    Zheng, Biao
    Liu, Longfei
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2024, 25 (15) : 2012 - 2021
  • [19] Emerging role of immunotherapy in the management of prostate cancer - The Slovin article reviewed
    Hauke, Ralph
    ONCOLOGY-NEW YORK, 2007, 21 (03): : 346 - 348
  • [20] The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise
    Che, Jizhong
    Liu, Yuanyuan
    Liu, Yangyang
    Song, Jingheng
    Cui, Hongguo
    Feng, Dongdong
    Tian, Aimin
    Zhang, Zhengchao
    Xu, Yankai
    FRONTIERS IN IMMUNOLOGY, 2025, 16